Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
Search Article 
Advanced search 
  Users Online: 274 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
This article has been cited by
1Graves’ Disease in Senegal: Clinical and Evolutionary Aspects
A. Sarr,D. Diédhiou,N. M. Ndour-Mbaye,D. Sow,I. M. Diallo,S. El Alaoui,M. Diouf,S. N. Diop
Open Journal of Internal Medicine.2016;06(03)77
299mTc-pertechnetate thyroid scintigraphy predicts clinical outcomes in personalized radioiodine treatment for Graves’ disease
Zhao Lina,Zhang Wenqi,Xin Yubo,Wen Qiang,Bail Lin,Guan Feng,Ji Bin
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition).2018;37(6)349
3Percentage and function of CD4+CD25+ regulatory T cells in patients with hyperthyroidism
Ting-Jun Jiang,Xue-Liang Cao,Sha Luan,Wan-Hui Cui,Si-Huang Qiu,Yi-Chao Wang,Chang-Jiu Zhao,Peng Fu
Molecular Medicine Reports.2017;37(6)349
4Predicción de los resultados clínicos en el tratamiento personalizado con yodo radiactivo de la enfermedad de Graves, mediante gammagrafía tiroidea con 99mTc-pertecnetato
L. Zhao,W. Zhang,Y. Xin,Q. Wen,L. Bail,F. Guan,Ji Bin
Revista Española de Medicina Nuclear e Imagen Molecular.2018;37(6)349

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal